| Name | RK-582 |
|---|
| Description | RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered. |
|---|
| Molecular Formula | C27H35FN6O3 |
|---|---|
| Molecular Weight | 510.6144 |